239 related articles for article (PubMed ID: 10216276)
1. Signalling sphingomyelinases: which, where, how and why?
Levade T; Jaffrézou JP
Biochim Biophys Acta; 1999 Apr; 1438(1):1-17. PubMed ID: 10216276
[TBL] [Abstract][Full Text] [Related]
2. Ceramide signalling and the immune response.
Ballou LR; Laulederkind SJ; Rosloniec EF; Raghow R
Biochim Biophys Acta; 1996 Jun; 1301(3):273-87. PubMed ID: 8664339
[TBL] [Abstract][Full Text] [Related]
3. Acid and neutral sphingomyelinases: roles and mechanisms of regulation.
Marchesini N; Hannun YA
Biochem Cell Biol; 2004 Feb; 82(1):27-44. PubMed ID: 15052326
[TBL] [Abstract][Full Text] [Related]
4. Neutral Sphingomyelinases in Cancer: Friend or Foe?
Clarke CJ
Adv Cancer Res; 2018; 140():97-119. PubMed ID: 30060818
[TBL] [Abstract][Full Text] [Related]
5. Sphingomyelin-degrading pathways in human cells role in cell signalling.
Levade T; Andrieu-Abadie N; Ségui B; Augé N; Chatelut M; Jaffrézou JP; Salvayre R
Chem Phys Lipids; 1999 Nov; 102(1-2):167-78. PubMed ID: 11001571
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a sphingomyelinase activity in Saccharomyces cerevisiae.
Ella KM; Qi C; Dolan JW; Thompson RP; Meier KE
Arch Biochem Biophys; 1997 Apr; 340(1):101-10. PubMed ID: 9126282
[TBL] [Abstract][Full Text] [Related]
7. Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses.
Wu BX; Clarke CJ; Hannun YA
Neuromolecular Med; 2010 Dec; 12(4):320-30. PubMed ID: 20552297
[TBL] [Abstract][Full Text] [Related]
8. Sphingomyelin hydrolysis during apoptosis.
Andrieu-Abadie N; Levade T
Biochim Biophys Acta; 2002 Dec; 1585(2-3):126-34. PubMed ID: 12531545
[TBL] [Abstract][Full Text] [Related]
9. Sphingomyelinase and membrane sphingomyelin content: determinants ofProximal tubule cell susceptibility to injury.
Zager RA; Burkhart KM; Johnson A
J Am Soc Nephrol; 2000 May; 11(5):894-902. PubMed ID: 10770967
[TBL] [Abstract][Full Text] [Related]
10. Sphingomyelinases and Liver Diseases.
Insausti-Urkia N; Solsona-Vilarrasa E; Garcia-Ruiz C; Fernandez-Checa JC
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33143193
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of sphingomyelin hydrolysis: targeting the lipid mediator ceramide as a key regulator of cellular fate.
Claus RA; Dorer MJ; Bunck AC; Deigner HP
Curr Med Chem; 2009; 16(16):1978-2000. PubMed ID: 19519377
[TBL] [Abstract][Full Text] [Related]
12. Role of ceramide/sphingomyelin (SM) balance regulated through "SM cycle" in cancer.
Taniguchi M; Okazaki T
Cell Signal; 2021 Nov; 87():110119. PubMed ID: 34418535
[TBL] [Abstract][Full Text] [Related]
13. Role of sphingomyelinases in neurological disorders.
Ong WY; Herr DR; Farooqui T; Ling EA; Farooqui AA
Expert Opin Ther Targets; 2015; 19(12):1725-42. PubMed ID: 26243307
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the ceramide level, a novel therapeutic concept?
Claus R; Russwurm S; Meisner M; Kinscherf R; Deigner HP
Curr Drug Targets; 2000 Sep; 1(2):185-205. PubMed ID: 11465070
[TBL] [Abstract][Full Text] [Related]
15. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling.
Wiegmann K; Schütze S; Machleidt T; Witte D; Krönke M
Cell; 1994 Sep; 78(6):1005-15. PubMed ID: 7923351
[TBL] [Abstract][Full Text] [Related]
16. Altered sphingomyelinase and ceramide expression in the setting of ischemic and nephrotoxic acute renal failure.
Zager RA; Conrad S; Lochhead K; Sweeney EA; Igarashi Y; Burkhart KM
Kidney Int; 1998 Mar; 53(3):573-82. PubMed ID: 9507201
[TBL] [Abstract][Full Text] [Related]
17. Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein.
Hofmeister R; Wiegmann K; Korherr C; Bernardo K; Krönke M; Falk W
J Biol Chem; 1997 Oct; 272(44):27730-6. PubMed ID: 9346915
[TBL] [Abstract][Full Text] [Related]
18. [Study of sphingomyelinase activity and sphingomyelin and ceramide levels in comparison with other lipid fractions of the cell nucleus in regenerating rat liver].
Pushkarev MIu; Borovkova OV; Alesenko AV
Biokhimiia; 1991 May; 56(5):903-12. PubMed ID: 1747416
[TBL] [Abstract][Full Text] [Related]
19. The IL-1 receptor signaling pathway.
Kuno K; Matsushima K
J Leukoc Biol; 1994 Nov; 56(5):542-7. PubMed ID: 7964161
[TBL] [Abstract][Full Text] [Related]
20. Sphingomyelinases in retinas and optic nerve heads: Effects of ocular hypertension and ischemia.
Fan J; Liu J; Liu J; Angel PM; Drake RR; Wu Y; Fan H; Koutalos Y; Crosson CE
Exp Eye Res; 2022 Nov; 224():109250. PubMed ID: 36122624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
